BiotechTubeBiotechTube
Home/Generate Biomedicines/Jane Mendillo
JM

Jane Mendillo

Director; Former CEO, Harvard Management Company

Generate Biomedicines

Therapeutic Areas

Immunology & InflammationOncology

Generate Biomedicines Pipeline

DrugIndicationPhase
GB-0895Severe AsthmaPhase 3
GB-4362Various (to reduce MMAE ADC toxicity)Preclinical
GB-5267Metastatic Ovarian CancerPreclinical
Multiple Preclinical ProgramsNot DisclosedPreclinical
Platform Collaboration Programs (Jan 2022)Not DisclosedDiscovery/Preclinical
Platform Collaboration Programs (Sep 2024)Not DisclosedDiscovery/Preclinical

Leadership Team at Generate Biomedicines

MN
Michael Nally
Chief Executive Officer
JS
Jason Silvers
President & Chief Financial Officer
AK
Aarif Khakoo
Chief Scientific Officer
LL
Laurie Lee
Chief Medical Officer, Immunology & Inflammation
GG
Gevorg Grigoryan
Co-Founder & Chief Technology Officer
SM
Sean Martin
Chief Legal Officer & General Counsel
KW
Kym White
Chief Corporate Affairs Officer
BG
Beth Grous
Chief People Officer
DD
Dinesh de Alwis
Senior Vice President, Head of Clinical Drug Development
DH
Daria Hazuda
Senior Vice President, Discovery Strategy
View full Generate Biomedicines profile